Phibro(PAHC) - 2025 Q2 - Quarterly Results

Highlights for the three months ended December 31, 2024 (compared to the three months ended December 31, 2023) We have updated our fiscal year 2025 guidance, which includes: COMMENTARY "Phibro has achieved exceptional results this quarter, fueled by robust demand in our Animal Health segment and the successful integration of the Zoetis Medicated Feed Additive (MFA) portfolio," stated Jack Bendheim, President and Chief Executive Officer. "Our impressive 24% revenue growth and notable enhancement in profitabi ...